Expand IRWD Menu
IRWD MENU

IRWD Latest Press Releases

-- September 3, 2026 --

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference Business Wire 4:06 PM

-- August 6, 2026 --

Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results Business Wire 7:05 AM

-- July 30, 2026 --

Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call Business Wire 4:05 PM

-- July 14, 2026 --

Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients Business Wire 7:30 AM

-- May 28, 2026 --

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference Business Wire 4:05 PM

-- May 27, 2026 --

FDA Approves Use of LINZESS (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC) Business Wire 10:00 AM

-- May 7, 2026 --

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance Business Wire 7:05 AM

-- May 4, 2026 --

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS) Business Wire 7:05 AM

-- April 30, 2026 --

Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call Business Wire 4:05 PM

-- April 23, 2026 --

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week 2026 Business Wire 7:05 AM
Market Data Delayed 15 Minutes